Last $16.32 MXN
Change Today -5.83 / -26.32%
Volume 63.9M
LABB On Other Exchanges
Symbol
Exchange
Berlin
OTC US
As of 4:09 PM 02/27/15 All times are local (Market data is delayed by at least 15 minutes).

genomma lab internacional-b (LABB) Snapshot

Open
$17.76
Previous Close
$22.15
Day High
$17.90
Day Low
$15.05
52 Week High
07/9/14 - $37.15
52 Week Low
02/27/15 - $15.05
Market Cap
17.1B
Average Volume 10 Days
10.4M
EPS TTM
$1.37
Shares Outstanding
1.0B
EX-Date
--
P/E TM
11.9x
Dividend
--
Dividend Yield
--
Current Stock Chart for GENOMMA LAB INTERNACIONAL-B (LABB)

Related News

No related news articles were found.

genomma lab internacional-b (LABB) Related Businessweek News

No Related Businessweek News Found

genomma lab internacional-b (LABB) Details

Genomma Lab Internacional, S.A.B. de C.V., together with its subsidiaries, develops, markets, and sells over-the-counter pharmaceutical products, generic drugs, and personal care products in Mexico and internationally. The company offers approximately 112 own brands covering various product categories, including anti-acne products, generic drugs, sexual protection and enhancement products, hemorrhoid treatments, varicose vein treatments, hair loss treatments, topical analgesics, antacids, topical antifungals, colitis treatments, anti stress treatments, osteoarthritis treatments, soaps, multivitamins, shampoos, and flu treatments, as well as creams to enhance the appearance of scars. It also provides air transportation services. The company was founded in 1996 and is based in Mexico City, México.

Founded in 1996

genomma lab internacional-b (LABB) Top Compensated Officers

No compensation data is available at this time for the top officers at this company.

Executives, Board Directors

genomma lab internacional-b (LABB) Key Developments

Genomma Lab Internacional SAB de CV Presents at 33rd Annual J.P. Morgan Healthcare Conference, Jan-13-2015 02:30 PM

Genomma Lab Internacional SAB de CV Presents at 33rd Annual J.P. Morgan Healthcare Conference, Jan-13-2015 02:30 PM. Venue: Westin St. Francis Hotel, San Francisco, California, United States. Speakers: Oscar Villalobos Torres, Vice-President of Finance & Administration and Member of Executive Committee.

Genomma Lab Internacional SAB de CV Reports Consolidated Earnings Results for the Third Quarter and Nine Months Ended September 30, 2014

Genomma Lab Internacional SAB de CV reported consolidated earnings results for the third quarter and nine months ended September 30, 2014. For the quarter, the company reported net sales of MXN 3,359.5 million against MXN 3,066.8 million a year ago. EBITDA was MXN 850.0 million against MXN 795.8 million a year ago. Operating income was MXN 823.8 million against MXN 780.7 million a year ago. Net income of majority shareholders was MXN 472.5 million against MXN 462.3 million a year ago. EPS was MXN 1.69 against MXN 1.59 a year ago. Income before income taxes was MXN 702,778,000 against MXN 731,336,000 a year ago. For the nine months, the company reported net sales of MXN 8,697.7 million against MXN 7,683.2 million a year ago. EBITDA was MXN 1,839.9 million against MXN 1,660.5 million a year ago. Operating income was MXN 1,770.7 million against MXN 1,614.7 million a year ago. Net income of majority shareholders was MXN 934.0 million against MXN 910.5 million a year ago. EPS was MXN 1.69 against MXN 1.59 a year ago. Income before income taxes was MXN 1,446,045,000 against MXN 1,410,321,000 a year ago. Net cash generated from operating activities was MXN 423,476,000 against MXN 651,895,000 a year ago. Investment in fixed assets was MXN 30,467,000 against MXN 85,428,000 a year ago.

Genomma Lab Internacional SAB de CV Presents at UBS Global Emerging Markets One-on-One Conference, Dec-02-2014

Genomma Lab Internacional SAB de CV Presents at UBS Global Emerging Markets One-on-One Conference, Dec-02-2014 . Venue: The Westin New York Grand Central, 212 East 42nd Street at 3rd Avenue, New York, New York, United States.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
LABB:MM $16.32 MXN -5.83

LABB Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for LABB.
View Industry Companies
 

Industry Analysis

LABB

Industry Average

Valuation LABB Industry Range
Price/Earnings 11.6x
Price/Sales 1.7x
Price/Book 2.2x
Price/Cash Flow 11.7x
TEV/Sales 1.1x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact GENOMMA LAB INTERNACIONAL-B, please visit www.genommalab.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.